Munsell MF - Search Results

1

Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.

Malpica A, Deavers MT, Tornos C, Kurman RJ, Soslow R, Seidman JD, Munsell MF, Gaertner E, Frishberg D, Silva EG. Malpica A, et al. Among authors: munsell mf. Am J Surg Pathol. 2007 Aug;31(8):1168-74. doi: 10.1097/PAS.0b013e31803199b0. Am J Surg Pathol. 2007. PMID: 17667538

2

Prognostic indicators for invasive carcinoma of the vulva.

Rutledge FN, Mitchell MF, Munsell MF, Atkinson EN, Bass S, McGuffee V, Silva E. Rutledge FN, et al. Among authors: munsell mf. Gynecol Oncol. 1991 Sep;42(3):239-44. doi: 10.1016/0090-8258(91)90352-6. Gynecol Oncol. 1991. PMID: 1955186

3

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.

Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH. Slomovitz BM, et al. Among authors: munsell mf. J Clin Oncol. 2004 Aug 1;22(15):3126-32. doi: 10.1200/JCO.2004.11.154. J Clin Oncol. 2004. PMID: 15284264

4

The activity of taxanes in the treatment of sex cord-stromal ovarian tumors.

Brown J, Shvartsman HS, Deavers MT, Burke TW, Munsell MF, Gershenson DM. Brown J, et al. Among authors: munsell mf. J Clin Oncol. 2004 Sep 1;22(17):3517-23. doi: 10.1200/JCO.2004.12.074. J Clin Oncol. 2004. PMID: 15337800

5

The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors.

Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, Gershenson DM. Brown J, et al. Among authors: munsell mf. Gynecol Oncol. 2005 May;97(2):489-96. doi: 10.1016/j.ygyno.2005.01.011. Gynecol Oncol. 2005. PMID: 15863149

6

Factors prognostic of survival in advanced-stage uterine serous carcinoma.

Holman LL, Pal N, Iglesias DA, Soliman PT, Balakrishnan N, Klopp A, Broaddus RR, Fleming ND, Munsell MF, Lu KH, Westin SN. Holman LL, et al. Among authors: munsell mf. Gynecol Oncol. 2017 Jul;146(1):27-33. doi: 10.1016/j.ygyno.2017.04.018. Epub 2017 Apr 30. Gynecol Oncol. 2017. PMID: 28465008 Free PMC article.

7

Impact of high-dose chemotherapy on peripheral T-cell lymphomas.

Rodriguez J, Munsell M, Yazji S, Hagemeister FB, Younes A, Andersson B, Giralt S, Gajewski J, de Lima M, Couriel D, Romaguera J, Cabanillas FF, Champlin RE, Khouri IF. Rodriguez J, et al. J Clin Oncol. 2001 Sep 1;19(17):3766-70. doi: 10.1200/JCO.2001.19.17.3766. J Clin Oncol. 2001. PMID: 11533100

8

Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?

Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF. Brown GA, et al. Among authors: munsell mf. BJU Int. 2006 Dec;98(6):1176-80. doi: 10.1111/j.1464-410X.2006.06524.x. BJU Int. 2006. PMID: 17125474

9

P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.

Kassouf W, Spiess PE, Brown GA, Munsell MF, Grossman HB, Siefker-Radtke A, Dinney CP, Kamat AM. Kassouf W, et al. Among authors: munsell mf. Eur Urol. 2007 Sep;52(3):769-74. doi: 10.1016/j.eururo.2007.03.086. Epub 2007 Apr 10. Eur Urol. 2007. PMID: 17434254 Free PMC article.

10

Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy.

Brown GA, Matin SF, Busby JE, Dinney CP, Grossman HB, Pettaway CA, Munsell MF, Kamat AM. Brown GA, et al. Among authors: munsell mf. Urology. 2007 Aug;70(2):252-6. doi: 10.1016/j.urology.2007.03.051. Urology. 2007. PMID: 17826484 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203 results

Search Page